e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
Emerging technologies for malignant pleural diseases management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Efficacy of recombinant adenoviral human p53 gene in treatment of lung cancer-mediated pleural effusion
Kunlin Li (Chongqing, China), Kun-lin Li, Jun Kang, Li Li, Yu-bo Wang, Yong He
Source:
International Congress 2015 – Emerging technologies for malignant pleural diseases management
Session:
Emerging technologies for malignant pleural diseases management
Session type:
Oral Presentation
Number:
5004
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kunlin Li (Chongqing, China), Kun-lin Li, Jun Kang, Li Li, Yu-bo Wang, Yong He. Efficacy of recombinant adenoviral human p53 gene in treatment of lung cancer-mediated pleural effusion. Eur Respir J 2015; 46: Suppl. 59, 5004
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
Elevated survivin is associated with a reduced survival in patients with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
Survival of non small cell lung carcinoma patients with malignant pleural effusions
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Activated KRAS signaling triggers malignant pleural effusion
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
Role of Dr-70 immunoassay in suspected malignant pleural effusion
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy
Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training
Year: 2014
What outcome after pleurodesis in malignant pleural effusion in lung cancer?
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level?
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
The protein DJ-1 in malignant pleural effusions due to lung cancer: Levels and correlations with oxidative stress biomarkers
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
CD33
+
CD14
-
CD11b
+
CD66b
+
CD15
+
VEGFR-1
hi
myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014
Breast metastasis from primary EGFR-mutated lung carcinoma or primary tumor?
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Recruitment and phenotypic characteristics of interleukin 9−Producing CD4
+
T cells in malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Cetuximab administered through pulmonary route in a mice model of lung tumor
Source: Annual Congress 2013 –Advances in the therapy of lung cancer
Year: 2013
Lung adenocarcinoma mimicking interstitial lung disease showed good response to navelbine monotherapy
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept